Stocks and Finance

Celgene

Celgene 2/29/2012

06:52 : ProMetic Finalizes Its Agreement With Celgene Corporation - LAVAL, QUEBEC--(Marketwire - Feb. 29, 2012) - ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") announced today that it has completed relevant milestones regarding the agreement ("Agreement") entered into in March 2011 with Celgene Corporation ...
Source : marketwire-com

Celgene 2/10/2012

17:42 : Morgan Stanley picks three biotechs worth buying: Biogen (BIIB), Celgene ... - Morgan Stanley picks three biotechs worth buying: Biogen (BIIB), Celgene (CELG) and Gilead Sciences (GILD). The latter "offers 15-20% upside and the most attractive combination of fundamental positive ...
Source : seekingalpha-com

Celgene 1/26/2012

13:37 : EntreMed rallies in wake of Celgene deal - BOSTON (MarketWatch) -- Shares of EntreMed Inc. rallied 23% to $2.89 on Thursday in the wake of news that partner Celgene Corp. was acquiring fellow cancer-therapy developer Avila Therapeutics for $350 million in cash and ...
Source : marketwatch-com
10:52 : Celgene profit jumps; to buy Avila - (Reuters) - Celgene Corp said fourth-quarter earnings nearly doubled on higher sales of its multiple myeloma drug Revlimid, and it disclosed plans to acquire smaller biotechnology company Avila...
Source : reuters-com
09:31 : Celgene to acquire Avila Therapeutics - (Reuters) - Celgene Corp said on Thursday that it would acquire Avila Therapeutics Inc, a privately held biotechnology company, for $350 million in cash.
Source : reuters-com

Celgene 1/9/2012

11:46 : Celgene ([[CELG]] +1.1%) states it expects 2011 revenue of $4.8B and EPS ... - Celgene (CELG +1.1%) states it expects 2011 revenue of $4.8B and EPS of $3.79, slightly below a consensus of $4.83B and $3.80. The drugmaker is also establishing 2012 revenue guidance $5.4B-$5.6B and EPS guidance of $4.70-$4.80, largely ...
Source : seekingalpha-com

Celgene 1/6/2012

10:29 : Lagging biotechs Amgen ([[AMGN]] -0.2%) and Celgene ([[CELG]] -2%) may ... - Lagging biotechs Amgen (AMGN -0.2%) and Celgene (CELG -2%) may dive into deal-making this year in seeking to return to the industry's high-growth roots, Bloomberg speculates. Investors in the space have rewarded strategic acquisitions ...
Source : seekingalpha-com
actualidad Celgene -
Logo Celgene


Biotechnology

Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts